Concourse Financial Group Securities, Inc. Emergent Bio Solutions Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$5.72 - $14.77 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$1.86 - $6.98 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$1.5 - $3.41 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$1.82 - $3.16 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$3.17 - $7.91 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	SELL	$3.17 - $7.91 $19 - $47	-6 Closed	0 $0
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $46 - $97	6 New	6 $0
Q4 2022 Jan 30, 2023	BUY	$11.0 - $21.45 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	SELL	$20.09 - $35.8 $1,125 - $2,004	-56 Closed	0 $0
Q2 2022 Aug 09, 2022	SELL	$27.42 - $43.63 $2,056 - $3,272	-75 Reduced 57.25%	56 $2,000
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $2,079 - $2,976	-57 Reduced 30.32%	131 $5,000
Q3 2021 Nov 09, 2021	BUY	$50.07 - $66.05 $7,860 - $10,369	157 Added 506.45%	188 $9,000
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $4,358 - $6,195	-77 Reduced 71.3%	31 $1,000
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $54,066 - $78,494	-627 Reduced 85.31%	108 $10,000
Q4 2020 Feb 02, 2021	BUY	$79.17 - $111.47 $19,792 - $27,867	250 Added 51.55%	735 $66,000
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $7,781 - $12,819	-95 Reduced 16.38%	485 $50,000
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $4,998 - $8,235	92 Added 18.85%	580 $46,000
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $2,417 - $3,369	-49 Reduced 9.12%	488 $28,000
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $14,492 - $16,713	283 Added 111.42%	537 $29,000
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $1,258 - $1,773	-31 Reduced 10.88%	254 $13,000
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $71,057 - $95,870	-1,780 Reduced 86.2%	285 $14,000
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $8,826 - $12,107	-183 Reduced 8.14%	2,065 $104,000
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $114,875 - $151,240	2,065 Added 1128.42%	2,248 $133,000
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $9,525 - $12,171	183 New	183 $12,000

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$36.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$32.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$23.6 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$21.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$18.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account